Skip to main content
. 2019 Oct 9;10(10):783. doi: 10.3390/genes10100783

Table 4.

Genotype frequencies of tested single nucleotide polymorphisms (SNPs) in the COPD cases and the control population and their associations with COPD adjusted for age, gender and smoking status.

Adjusted for Age/Gender/Smoking
SNP Genotype COPD Cases Controls OR (95%CI 2) 1 p
rs12150220 A/A 113 (29.20%) 307 (24.64%) 1.00
A/T 190 (49.10%) 642 (51.52%) 0.54 (0.31–0.95) 0.03 *
T/T 84 (21.71%) 297 (23.84%) 0.59 (0.28–1.26) 0.17
A/T+T/T 274 (70.80%) 939 (75.36%) 0.55 (0.32–0.95) 0.03 *
rs35596958 T/T 335 (86.79%) 1086 (87.16%) 1.00
C/T 49 (12.69%) 160 (12.84%) 0.86 (0.42–1.78) 0.69
C/C 2 (0.52%) 0 (0.00%) - -
rs1043673 C/C 152 (39.79%) 471 (37.83%) 1.00
A/C 177 (46.34%) 589 (47.31%) 1.13 (0.65–1.95) 0.67
A/A 53 (13.87%) 185 (14.86%) 0.92 (0.42–2.01) 0.83
rs35829419 C/C 346 (89.41%) 1141 (91.35%) 1.00
A/C 39 (10.08%) 107 (8.57%) 1.07 (0.44–2.58) 0.88
A/A 2 (0.52%) 1 (0.08%) - 0.80
rs441827 C/C 155 (40.16%) 464 (37.09%) 1.00
T/C 168 (43.52%) 598 (47.80%) 0.82 (0.47–1.44) 0.49
T/T 63 (16.32%) 189 (15.11%) 1.02 (0.50–2.10) 0.95
rs12462372 G/G 354 (91.00%) 1092 (88.21%) 1.00
A/G 34 (8.74%) 143 (11.55%) 0.36 (0.15–0.90) 0.03 *
A/A 1 (0.26%) 3 (0.24%) 0.29 (0.00–949.77) 0.77
A/G+A/A 35 (9.00%) 146 (11.79%) 0.36 (0.15–0.90) 0.03 *
rs17857373 G/G 359 (92.76%) 1162 (92.89%) 1.00
C/G 26 (6.72%) 88 (7.03%) 0.96 (0.34–2.69) 0.94
C/C 2 (0.52%) 1 (0.08%) - -
rs302453 A/A 215 (55.41%) 681 (54.83%) 1.00
A/T 159 (40.98%) 471 (37.92%) 1.59 (0.94–2.71) 0.09
T/T 14 (3.61%) 90 (7.25%) 0.31 (0.09–0.99) 0.05
rs10409555 G/G 212 (54.78%) 664 (53.12%) 1.00
A/G 142 (36.69%) 495 (39.60%) 0.59 (0.34–1.03) 0.06
A/A 33 (8.53%) 91 (7.28%) 1.75 (0.73–4.20) 0.21
rs16986899 T/T 268 (69.79%) 857 (68.89%) 1.00
C/T 104 (27.08%) 348 (27.97%) 1.17 (0.66–2.07) 0.60
C/C 12 (3.13%) 39 (3.14%) 0.77 (0.19–3.06) 0.71
rs471979 G/G 293 (79.62%) 962 (80.37%) 1.00
C/G 68 (18.48%) 219 (18.30%) 0.72 (0.36–1.43) 0.35
C/C 7 (1.90%) 16 (1.34%) 4.14 (0.93–18.49) 0.06
rs56159585 T/T 320 (82.69%) 969 (79.23%) 1.00
A/T 61 (15.76%) 238 (19.46%) 0.54 (0.27–1.07) 0.08
A/A 6 (1.55%) 16 (1.31%) 0.11 (0.00–4.43) 0.24
rs77447196 C/C 265 (68.48%) 823 (66.42%) 1.00
C/G 117 (30.23%) 363 (29.30%) 0.72 (0.40–1.29) 0.27
G/G 5 (1.29%) 53 (4.28%) 0.38 (0.07–2.12) 0.27
rs306457 C/C 227 (58.81%) 757 (60.71%) 1.00
C/G 134 (34.72%) 413 (33.12%) 1.08 (0.63–1.85) 0.77
G/G 25 (6.48%) 77 (6.17%) 0.39 (0.12–1.30) 0.12
rs306481 G/G 142 (36.50%) 405 (32.58%) 1.00
A/G 190 (48.84%) 604 (48.59%) 0.95 (0.55–1.65) 0.86
A/A 57 (14.65%) 234 (18.83%) 0.60 (0.27–1.33) 0.21
rs12461110 G/G 158 (41.15%) 501 (40.14%) 1.00
A/G 160 (41.67%) 568 (45.51%) 0.76 (0.44–1.33) 0.34
A/A 66 (17.19%) 179 (14.34%) 1.26 (0.61–2.61) 0.54
rs299163 A/A 349 (89.95%) 1066 (85.76%) 1.00
A/C 38 (9.79%) 172 (13.84%) 0.93 (0.46–1.90) 0.85
C/C 1 (0.26%) 5 (0.40%) 0.02 (0.00–11710.48) 0.57
rs34436714 C/C 251 (65.88%) 771 (61.98%) 1.00
A/C 117 (30.71%) 407 (32.72%) 0.62 (0.35–1.08) 0.09
A/A 13 (3.41%) 66 (5.31%) 0.40 (0.11–1.43) 0.16
rs34971363 G/G 325 (83.98%) 1049 (83.79%) 1.00
C/G 60 (15.50%) 191 (15.26%) 1.26 (0.62–2.58) 0.52
C/C 2 (0.52%) 12 (0.96%) 0.41 (0.01–31.83) 0.69
rs303997 C/C 124 (32.12%) 418 (33.63%) 1.00
C/T 201 (52.07%) 630 (50.68%) 1.13 (0.65–1.98) 0.67
T/T 61 (15.80%) 195 (15.69%) 1.09 (0.51–2.30) 0.83

* p values <0.05 1 OR, odds ratio 2 CI, confidence interval.